Prevalence and Prognosis of Cardiac Amiloidosis in Turkey

Turkish Society of Cardiology2,087 enrolled

Overview

Patients with left ventricular hypertrophy are further examined according to an algorithm to check if they have a cardiac amyloidosis

Study Type

OBSERVATIONAL

Enrollment

2,087

Conditions

Cardiac Amyloidosis

Interventions

AlgorithmBEHAVIORAL

Algorithm

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with left ventricular hypertrophy without left ventricular pressure or volume (IVS≥13mm) * Patients with left ventricular hypertrophy and hypertension or aortic stenosis without left ventricular pressure or volume (IVS\>15mm) Exclusion Criteria: * Patients with left ventricular pressure or volume except the ones with aortic stenosis and arterial hypertension * Patients with sigmoid septum and their hypertrophy limited in sigmoid area * Patients with highly probable sarcometric hypertrophy cardiomyopathy confirmed with LV morhpology and genetic testing

Locations (1)

Dokuz Eylul University Faculty of Medicine

Izmir, Turkey (Türkiye)

RECRUITING

Outcomes

Primary Outcomes

Cardiac Amyloidosis

Patients with left ventricular hypertrophy and Cardiac Amyloidosis

Time frame: Upon screening

Central Contacts

Ilkay Gucuk, MD

CONTACT

902122211738 tkd@tkd.org.tr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.